ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
200.29
+1.69 (0.85%)
At close: Jun 26, 2026, 4:00 PM EDT
201.00
+0.71 (0.35%)
After-hours: Jun 26, 2026, 7:40 PM EDT

ResMed Stock Forecast

Stock Price Forecast

According to 19 analysts polled by S&P Global, ResMed stock has a consensus rating of "Buy" and an average price target of $260.6. The average 1-year stock price forecast is 30.11% higher than the current stock price, while the lowest is $180 (-10.13%) and the highest is $325 (+62.26%).

Price Target: $260.6 (+30.11%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$180$260.6$240$325
Change-10.13%+30.11%+19.83%+62.26%

Analyst Ratings

The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy888799
Buy333321
Hold777778
Sell000000
Strong Sell111111
Total191919181919

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 22, 2026
KeyBanc
KeyBanc
Buy
Reiterates
$290$266
BuyReiterates$290$266+32.81%Jun 22, 2026
Morgan Stanley
Morgan Stanley
Hold
Downgrades
$286$230
HoldDowngrades$286$230+14.83%Jun 17, 2026
Citi
Citi
Buy
Reiterates
$340$270
BuyReiterates$340$270+34.80%Jun 15, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$320
BuyReiterates$320+59.77%Jun 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.65B
from 5.15B
Increased by 9.81%
Revenue Next Year
6.10B
from 5.65B
Increased by 7.87%
EPS This Year
11.11
from 9.55
Increased by 16.34%
EPS Next Year
12.10
from 11.11
Increased by 8.94%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026
Revenue
3.20B3.58B4.22B4.69B5.15B5.65B
Revenue Growth
8.11%11.93%18.02%10.95%9.84%9.81%
Gross Profit
1.89B2.06B2.39B2.69B3.09B3.53B
Gross Margin
59.10%57.68%56.50%57.38%59.99%62.49%
Operating Income
917.55M1.00B1.15B1.38B1.69B2.03B
Net Income
474.51M779.44M897.56M1.02B1.40B1.55B
EPS
----9.5511.11
EPS Growth
----23.70%16.34%
Forward PE
45.8134.1030.8222.8625.3218.03
Dividend / Share
1.591.681.761.922.122.43
Dividend Growth
-5.66%4.76%9.09%10.42%14.64%
Free Cash Flow
779.72M127.68M400.59M1.18B1.21B1.62B
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High5.7B
Avg5.7B
Low5.6B

Revenue Growth

Revenue Growth202620272028
High
10.5%
Avg
9.8%
Low
9.3%

EPS Forecast

EPS202620272028
High11.20
Avg11.11
Low10.98

EPS Growth

EPS Growth202620272028
High
17.3%
Avg
16.3%
Low
15.0%